Kim Bullock

Clinical Focus

• Psychiatry
• Conversion Disorder
• Cognitive Behavior Therapy
• Non-epileptic Seizures

Honors and Awards

• Special Thanks and Recognition Award, Palo Alto Veterans Administration (July 1998)
• Donald Glew Award for Student Research, George Washington University (1994)
• William Beaumont Society Research Award, William Beaumont Society Research Award, George Washington University (1990)
• Chancellor's Leadership Award, University of California, San Diego (1989)
• Departmental Honors with Distinction in Psychology, University of California, San Diego (1989)

Professional Education

• Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2006)
• SUMC - Graduate Medical Education (2002) CA
• Washington Hospital Center (1995) DC
• George Washington University (1994) D.C.
• Residency, Stanford University Psychiatry (2002)
• Internship, Washington Hospital Center Internal Medicine (1995)
• MD, George Washington University Medicine (1994)
• BA, University of California Animal Physiology (1989)
• BA, University of California Psychology (1989)

Community & International Work

• Vice President of Peninsula Community Services, San Mateo More »
• United Nations Association More »
• Physicians for Social Responsibility More »
• African Library Project More »
• Team in Training More »

Web Site Links

• Neuropsychiatry Lab

Research Interests

Group and individual treatment of psychogenic seizures using cognitive behavioral therapy, assertiveness/ interpersonal communication skills, and autonomic nervous system modulation. Internal locus of control treatments for psychiatric illness.

Publications

• Group therapy for patients with psychogenic nonepileptic seizures: a pilot study. Barry JJ,  Wittenberg D, Bullock KD, Michaels JB, Classen CC, Fisher RS.  Epilepsy Behav.  2008; 13 (4): 624-9
• Doubl-blind, 0nce-weekly Oral Morphine in Treatment Resistant Obsessive-Compulsive Disorder Koran, Lorrin,  Elias Aboujaoude, Kim Bullock, Nona Gamel.  The Journal of Clinical Psychiatry.  2005;
• Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. Koran LM,  Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M.  J Clin Psychiatry.  2005; 66 (3): 353-9
• Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices. Barry JJ,  Lembke A, Bullock KD.  Clin EEG Neurosci.  2004; 35 (1): 4-13
• Group psychotherpy for patients with non-epileptic seizures: a pilot study (abstract). Wittenberg D,  Michaels J, Ford C, Bullock K, Barry JJ.  Epilepsia.  2004; 45 (Suppl. 7): 57-8
• Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation. Koran LM,  Chuong HW, Bullock KD, Smith SC.  J Clin Psychiatry.  2003; 64 (7): 793-8
• Psychopharmacology of compulsive buying Bullock KD,  Koran LM.  Drugs of Today.  2003; 39 (9): 695-700
• Citalopram treatment of compulsive shopping: an open-label study. Koran LM,  Bullock KD, Hartston HJ, Elliott MA, D'Andrea V.  J Clin Psychiatry.  2002; 63 (8): 704-8
• Reduced mortality risk in alcoholics who achieve long-term abstinence. Bullock KD,  Reed RJ, Grant I.  JAMA.  1992; 267 (5): 668-72